Concepedia

Cláudia M. Calvet

CM

32

Publications

1K

Citations

24

H-Index

2003

Active since

Affiliations

Fundação Oswaldo Cruz(Current)

University of California San Diego

Center for Discovery

Universidade Federal Fluminense

University of California, San Francisco

Cláudia M. Calvet is an author at Fundação Oswaldo Cruz specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

2003–2021

32

Publications

32

Diverse Inhibitor Chemotypes Targeting Trypanosoma cruzi CYP51

Shamila S. Gunatilleke, Cláudia M. Calvet, Jonathan B. Johnston et al. · PLoS neglected tropical diseases · 2012 · 65 citations · Full text

A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease

Bianca Olivieri, Judith Molina, Solange L. de Castro et al. · International Journal of Antimicrobial Agents · 2010 · 63 citations

CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM)

Anjan Debnath, Cláudia M. Calvet, Gareth K. Jennings et al. · PLoS neglected tropical diseases · 2017 · 57 citations · Full text

Rational Development of 4-Aminopyridyl-Based Inhibitors Targeting Trypanosoma cruzi CYP51 as Anti-Chagas Agents

Jun Yong Choi, Cláudia M. Calvet, Shamila S. Gunatilleke et al. · Journal of Medicinal Chemistry · 2013 · 51 citations · Full text

SB-431542, a Transforming Growth Factor β Inhibitor, Impairs<i>Trypanosoma cruzi</i>Infection in Cardiomyocytes and Parasite Cycle Completion

Mariana Caldas Waghabi, Michelle Kéramidas, Cláudia M. Calvet et al. · Antimicrobial Agents and Chemotherapy · 2007 · 50 citations · Full text

, , +15

Rows per page

1–5 of 32